HALISTER: Lilly’s Gastric Cancer Drug Gains Approved From U.S. Regulators

Lilly’s Gastric Cancer Drug Gains Approved From U.S. Regulators

Alert: HALISTER Source: BN (Bloomberg News)

Tickers LLY US (Eli Lilly & Co) 3400398Z US (HHS Food & Drug Administration)

People Richard Pazdur (HHS Food & Drug Administration)

Topics Cancers Stomach Cancer Medical, Health Research Colon Cancer

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283